CTSS inhibition caused antigen diversification in non-Hodgkin lymphoma that switched immunity by promoting CD8+ T cell polyclonal expansion and suppressing CD4+ T cells [55]. The gene discussed is CD8A; the disease is non-Hodgkin lymphoma.